Berry Genomics Co.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 865.61 million compared to CNY 1,053.34 million a year ago. Revenue was CNY 865.61 million compared to CNY 1,053.34 million a year ago.

Net loss was CNY 134.96 million compared to CNY 16.19 million a year ago. Basic loss per share from continuing operations was CNY 0.3818 compared to CNY 0.0458 a year ago. Diluted loss per share from continuing operations was CNY 0.3818 compared to CNY 0.0458 a year ago.